Patient Affordability Introduction

This page includes resources for health care professionals to share with patients using SIMPONI® (golimumab) and their family members and caregivers. Please click on any of the links below to get more detailed information.

Open Enrollment Brochure. Even if patients keep the same health plan, benefits can change. The information in the Open Enrollment brochure can help patients make sure they have the coverage needed beginning January 1, 2015.

Janssen Prescription Assistance for SIMPONI® (golimumab). Click here for information about prescription assistance programs sponsored by relevant Janssen Pharmaceutical Companies as well as up-to-date information about independent foundations that may have available funding to help minimize drug costs for SIMPONI®.

SimponiOne®. Your one source for support for people receiving treatment with SIMPONI® (golimumab). The personalized Care Coordination services offered by SimponiOne® make it easy for you to get the help you need to make your treatment with SIMPONI® (golimumab) convenient.

SimponiOne® Cost Support. SimponiOne® Cost Support, for those eligible, may provide instant savings on your out-of-pocket medication costs for SIMPONI® for up to 12 months after activation or $10,000 annual program benefit, whichever comes first.

For eligibility, requirements, and restrictions, click here to download the SimponiOne® Cost Support Guide.

You may be able to save beyond the first year with verification of continued eligibility and annual re-enrollment. A SimponiOne® Care Coordinator will contact you before your enrollment period ends to review your continued eligibility for the next 12 months of benefits. If eligible, you'll continue to pay $5 a month for your SIMPONI® medication.

Johnson & Johnson Patient Assistance Foundation. Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to medicines for uninsured individuals who lack the financial resources to pay for them. If your patient needs SIMPONI® (golimumab), and is uninsured and unable to pay for their medicine, please have them contact a JJPAF program specialist at 1-800-652-6227 9 AM to 6 PM ET or visit the foundation website at to see if they might qualify for assistance.

October 20, 2014